wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
1
Q38632525-5AEC0BAE-5401-4BB4-AA9C-C24C5B0AC311
Q38632525-5AEC0BAE-5401-4BB4-AA9C-C24C5B0AC311
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38632525-5AEC0BAE-5401-4BB4-AA9C-C24C5B0AC311
Improvements in psoriasis within different body regions vary over time following treatment with ixekizumab.
P2860
Q38632525-5AEC0BAE-5401-4BB4-AA9C-C24C5B0AC311
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38632525-5AEC0BAE-5401-4BB4-AA9C-C24C5B0AC311
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
5d0d0c6087fa9e6d39469a0a98e30ccaced7a003
P2860
Sustained response with ixekizumab treatment of moderate-to-severe psoriasis with scalp involvement: results from three phase 3 trials (UNCOVER-1, UNCOVER-2, UNCOVER-3).